The nationwide deployment of EyeCheckup AI continues to expand, bringing AI-assisted diabetic retinopathy screening to additional hospitals and regions across Turkey.
Following the successful launch of the national screening initiative, deployment is now underway in multiple cities, demonstrating the scalability of AI-powered retinal screening in routine healthcare.
Expanding Across Multiple Cities
EyeCheckup AI is currently supporting screening activities in several locations, including:
- Ankara
- Erzurum
- Van
The rollout will continue as additional hospitals join the national program.
Supporting Leading Healthcare Institutions
Current deployment sites include several major healthcare institutions, including:
- Ankara Onkoloji Hastanesi
- Gülhane Eğitim ve Araştırma Hastanesi
- Van Yüzüncü Yıl Üniversitesi
These deployments demonstrate how AI can be integrated into existing hospital workflows while supporting clinicians in the early identification of diabetic retinopathy.
From Innovation to Clinical Practice
Artificial intelligence has attracted significant attention in medical imaging over recent years. The true measure of success, however, is real-world clinical implementation.
The ongoing nationwide rollout illustrates how AI can move beyond research studies and become part of everyday healthcare delivery, helping clinicians improve efficiency while expanding patient access to retinal screening.
Continuing the Journey
The expansion across Turkey is an important milestone, but it is only the beginning.
As additional cities and hospitals join the program, EyeCheckup remains committed to supporting healthcare providers with clinically validated AI technology that enables earlier detection, more efficient clinical workflows, and better outcomes for patients at risk of diabetic retinopathy.
